Munir, R.; Schapkaitz, E.; Noble, L.; Loonat, S.; McCree, M.; Ali, N.; Jacobson, B.; Stevens, W.S.; Scott, L.E.
A Comprehensive Clinical Assessment of the LumiraDx International Normalized Ratio (INR) Assay for Point-of-Care Monitoring in Anticoagulation Therapy. Diagnostics 2024, 14, 2683.
https://doi.org/10.3390/diagnostics14232683
AMA Style
Munir R, Schapkaitz E, Noble L, Loonat S, McCree M, Ali N, Jacobson B, Stevens WS, Scott LE.
A Comprehensive Clinical Assessment of the LumiraDx International Normalized Ratio (INR) Assay for Point-of-Care Monitoring in Anticoagulation Therapy. Diagnostics. 2024; 14(23):2683.
https://doi.org/10.3390/diagnostics14232683
Chicago/Turabian Style
Munir, Riffat, Elise Schapkaitz, Lara Noble, Sakina Loonat, Melanie McCree, Nazeer Ali, Barry Jacobson, Wendy Susan Stevens, and Lesley Erica Scott.
2024. "A Comprehensive Clinical Assessment of the LumiraDx International Normalized Ratio (INR) Assay for Point-of-Care Monitoring in Anticoagulation Therapy" Diagnostics 14, no. 23: 2683.
https://doi.org/10.3390/diagnostics14232683
APA Style
Munir, R., Schapkaitz, E., Noble, L., Loonat, S., McCree, M., Ali, N., Jacobson, B., Stevens, W. S., & Scott, L. E.
(2024). A Comprehensive Clinical Assessment of the LumiraDx International Normalized Ratio (INR) Assay for Point-of-Care Monitoring in Anticoagulation Therapy. Diagnostics, 14(23), 2683.
https://doi.org/10.3390/diagnostics14232683
